The program referred to the multi-district litigation over the implants as the largest such litigation since asbestos, according to a press release.
In early 2016, the FDA reclassified surgical meshes to treat pelvic organ prolapse in women as a Class III device, moving it up from a Class II classification.
Research has indicated that meshes used transvaginal procedures to treat pelvic organ prolapse can lead to complications including mesh erosion, pain, organ perforation, urinary issues and bleeding and infection.
60 Minutes will be speaking to Marlborough, Mass.-based Boston Scientific about the 48,000 lawsuits they’re facing, according to the release, nearly half of the more than 100,000 women who’ve filed suit against mesh makers. The episode is slated to air at 7:00 p.m. EDT on Sunday.
In February, Boston Scientific lost another bid as looking to overturn an $18.5 million loss in a product liability suit over alleged injuries caused by its Obtryx pelvic mesh.
This year’s DeviceTalks Minnesota features four tracks packed with expertly curated content created by the industry for the industry.
ECO-SYSTEM TRACK: focuses on issues impacting medtech companies across Minnesota and beyond. TECHNOLOGY TRACK: drills down on the hottest new tech that is changing medtech. REGULATORY 201 and CLINCAL 201 TRACKS: Hosted by Medical Alley and focuses on the most important trends in regulatory and clinical development.
Take a look at our full agenda.
Use the code "TRACKS" to save 15% on the cost of registration.